RilmakalimAlternative Names: HOE 234; Rimalkalim
Latest Information Update: 26 Jul 2002
At a glance
- Originator Aventis
- Class Antiasthmatics; Antihypertensives; Bronchodilators; Chromans; Pyrrolidines; Small molecules
- Mechanism of Action KATP channel stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma; Coronary disorders